| 000 | 00912 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250513063315.0 | ||
| 264 | 0 | _c19940520 | |
| 008 | 199405s 0 0 eng d | ||
| 022 | _a0966-8519 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGrunkemeier, G L | |
| 245 | 0 | 0 |
_aSample size requirements for evaluating heart valves with constant risk events. _h[electronic resource] |
| 260 |
_bThe Journal of heart valve disease _cJan 1994 |
||
| 300 |
_a53-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aGuidelines as Topic |
| 650 | 0 | 4 |
_aHeart Valve Prosthesis _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPoisson Distribution |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 | _aUnited States Food and Drug Administration |
| 700 | 1 | _aJohnson, D M | |
| 700 | 1 | _aNaftel, D C | |
| 773 | 0 |
_tThe Journal of heart valve disease _gvol. 3 _gno. 1 _gp. 53-8 |
|
| 999 |
_c8161539 _d8161539 |
||